Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

Savant Capital LLC lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 14.4% in the 4th ...

Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...

Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of ...

As of Thursday morning, IDEXX Laboratories shares are down by 0.49%, with a current price of $455.12. This implies that Erickson's 1,544 shares have a value of $597,944.

Shares of IDEXX Laboratories Inc. IDXX shed 1.38% to $457.35 Wednesday, on what proved to be an all-around poor trading ...

The Wednesday morning market activity shows IDEXX Laboratories shares down by 0.74%, trading at $460.32. This implies a total value of $4,280,728 for Fennell's 11,242 shares.

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

IDEXX Laboratories (IDXX) closed up more than +11% to lead gainers in the S&P 500 and Nasdaq 100 after reporting Q4 RPS of $2.62, better than the consensus of $2.41 and forecast 2025 EPS of $11.74-$12 ...